These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 433766)

  • 21. Adverse reaction to disopyramide.
    Dibble JB; Webster NR
    Postgrad Med J; 1979 Sep; 55(646):570-2. PubMed ID: 514940
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical studies of Norpace. Summarizing remarks.
    Fowler NO
    Angiology; 1975 Jan; 26(1 Pt 2):154-5. PubMed ID: 1090216
    [No Abstract]   [Full Text] [Related]  

  • 23. A randomized, double-blind, parallel group comparison of disopyramide phosphate and quinidine in patients with cardiac arrhythmias.
    Arif M; Laidlaw JC; Oshrain C; Willis PW; Nissen CH; McDermott DJ; Smith WS; Karim A; Wilson RR
    Angiology; 1983 Jun; 34(6):393-400. PubMed ID: 6408949
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Intravenously disopyramide phosphate administration for treatment of arrhythmias].
    Aquaro G; Belli R; Pavia M; Rey L; Ravera A; Possavino G; Idone P
    G Ital Cardiol; 1982; 12(7):509-19. PubMed ID: 7169147
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term therapy with disopyramide phosphate: side effects and effectiveness.
    Bauman JL; Gallastegui J; Strasberg B; Swiryn S; Hoff J; Welch WJ; Bauernfeind RA
    Am Heart J; 1986 Apr; 111(4):654-60. PubMed ID: 3082173
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral disopyramide for the prevention of arrhythmias in patients with acute myocardial infarction admitted to open wards.
    Zainal N; Carmichael DJ; Griffiths JW; Besterman EM; Kidner PH; Gillham AD; Summers GD
    Lancet; 1977 Oct; 2(8044):887-9. PubMed ID: 72237
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quinidine-induced ventricular flutter and fibrillation without digitalis therapy.
    Koster RW; Wellens HJ
    Am J Cardiol; 1976 Oct; 38(4):519-23. PubMed ID: 970334
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiovascular collapse associated with disopyramide therapy.
    Desai JM; Scheinman MM; Hirschfeld D; Gonzalez R; Peters RW
    Chest; 1981 May; 79(5):545-51. PubMed ID: 7226932
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Disopyramide-induced ventricular tachycardia.
    Lo KS; Gantz KB; Stetson PL; Lucchesi BR; Pitt B
    Arch Intern Med; 1980 Mar; 140(3):413-4. PubMed ID: 6153888
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of intravenous disopyramide in acute cardiac arrhythmias.
    De Backer M; Stoupel E; Kahn RJ
    Eur J Clin Pharmacol; 1981 Jan; 19(1):11-8. PubMed ID: 6161824
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Disopyramide in patients with the Wolff-Parkinson-White syndrome and atrial fibrillation.
    Bennett DH
    Chest; 1978 Dec; 74(6):624-8. PubMed ID: 738119
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Disopyramide-induced heart block.
    Timins BI; Gutman JA; Haft JI
    Chest; 1981 Apr; 79(4):477-9. PubMed ID: 7226916
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of intravenous disopyramide phosphate on recurrent paroxysmal tachycardias.
    Camm J; Ward D; Spurrell RA
    Br J Clin Pharmacol; 1979 Nov; 8(5):441-9. PubMed ID: 508548
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effect of intravenous disopyramide in supraventricular paroxysmal tachycardia refractory to vagal maneuvers].
    Romero-Ayala LC; Soní J
    Arch Inst Cardiol Mex; 1983; 53(2):147-51. PubMed ID: 6882095
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The antiarrhythmic effect of intravenous disopyramide in an open study.
    Tonkin AM; Heddle WF; Bett JH; Kemp RJ; Donnelly GL; Nelson GI; Manolas E; Sloman JG
    Aust N Z J Med; 1982 Aug; 12(4):271-5. PubMed ID: 6958238
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Disopyramide: evaluation of electrophysiologic effects and clinical efficacy in patients with sustained ventricular tachycardia or ventricular fibrillation.
    Lerman BB; Waxman HL; Buxton AE; Josephson ME
    Am J Cardiol; 1983 Mar; 51(5):759-64. PubMed ID: 6829435
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Data on disopyridamide therapy of some arrhythmias].
    Perroni GB; Briguglio FS; Oddo A; Trovato G
    Minerva Med; 1977 Jun; 68(32):2271-4. PubMed ID: 69277
    [No Abstract]   [Full Text] [Related]  

  • 38. Disopyramide (Norpace) for ventricular arrhythmias.
    Med Lett Drugs Ther; 1977 Dec; 19(25):101-2. PubMed ID: 593226
    [No Abstract]   [Full Text] [Related]  

  • 39. Comparison of the antiarrhythmic efficacy of disopyramide and mexiletine against stimulus-induced ventricular tachycardia.
    Breithardt G; Seipel L; Abendroth RR
    J Cardiovasc Pharmacol; 1981; 3(5):1026-37. PubMed ID: 6168848
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Oral longterm therapy with disopyramide phosphate in patients with atrial and ventricular arrhythmias (author's transl)].
    Stauch M; Grewe N
    MMW Munch Med Wochenschr; 1977 Dec; 119(48):1563-6. PubMed ID: 74799
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.